Business Description

Genomed SA
NAICS : 325412 SIC : 2834
ISIN : PLGNOMD00024
http://www.genomed.pl
Ulica Ponczowa 12, Warszawa, POL, 02-971
Compare
Compare
WAR:BMXWAR:IGNTMODHRSHSE:603259IDXXIQVAXSWX:LONNMTDICLRILMNLHDGXWATXPAR:BIMEXASRVTYXPAR:ERFASX:SHL
Traded in other countries / regions
GEN.Poland
IPO Date
2011-05-30
Description
Genomed SA assembles outstanding molecular biologists and genetic diagnosticians. The company provides diagnostic service that comprises DNA analysis and congenital diseases diagnostics based on DNA sequencing. It offers Diagnostic service and Service for scientific purposes.

Financial Strength

9/10
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.88
Interest Coverage 4.2
Piotroski F-Score 8/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 20.28
Distress
Grey
Safe
Beneish M-Score -2.73
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

7/10
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 6.2
3-Year EBITDA Growth Rate 14.4
3-Year EPS without NRI Growth Rate 31
3-Year FCF Growth Rate 25.9
3-Year Book Growth Rate 10

Momentum Rank

1/10
Name Current Vs Industry Vs History
5-Day RSI 43.93
9-Day RSI 40.13
14-Day RSI 32.59
6-1 Month Momentum % -6.04
12-1 Month Momentum % -20.9

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.38
Quick Ratio 5.11
Cash Ratio 3.32
Days Inventory 97.83
Days Sales Outstanding 25.95
Days Payable 30.86

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

8/10
Name Current Vs Industry Vs History
Gross Margin % 63.34
Operating Margin % 3.7
Net Margin % 2.1
FCF Margin % -0.8
ROE % 4.96
ROA % 4.32
ROIC % 9.52
ROC (Joel Greenblatt) % 14.48
ROCE % 6.22
Years of Profitability over Past 10-Year 10

GF Value Rank

8/10
Name Current Vs Industry Vs History
PE Ratio 81.16
PE Ratio without NRI 81.16
Shiller PE Ratio 38.97
Price-to-Owner-Earnings 69.14
PS Ratio 1.7
PB Ratio 3.92
Price-to-Tangible-Book 3.95
Price-to-Operating-Cash-Flow 30.27
EV-to-EBIT 57.38
EV-to-EBITDA 28.71
EV-to-Revenue 1.54
EV-to-FCF -193.68
Price-to-Projected-FCF 4.49
Price-to-Median-PS-Value 0.84
Price-to-Graham-Number 3.77
Price-to-Net-Current-Asset-Value 6.47
Price-to-Net-Cash 19.86
Earnings Yield (Greenblatt) % 1.74
FCF Yield % -0.47
Forward Rate of Return (Yacktman) % -8.35

Financials

WAR:GEN's 30-Y Financials
AAPL
Income Statement Breakdown FY
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Genomed SA Executives

Details

GF Value: zł39.9

WAR:GEN

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil zł) 21.732
EPS (TTM) (zł) 0.345
Beta 0.07
Volatility % 14.11
14-Day RSI 32.59
14-Day ATR (zł) 0.031963
20-Day SMA (zł) 28.01
12-1 Month Momentum % -20.9
52-Week Range (zł) 28 - 38
Shares Outstanding (Mil) 1.32

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Genomed SA Filings

Filing Date Document Date Form
No Filing Data

Genomed SA Stock Events

Financials Calendars
Event Date Price(zł)
No Event Data

Genomed SA Frequently Asked Questions

What is Genomed SA(WAR:GEN)'s stock price today?
The current price of WAR:GEN is zł28.00. The 52 week high of WAR:GEN is zł38.00 and 52 week low is zł28.00.
When is next earnings date of Genomed SA(WAR:GEN)?
The next earnings date of Genomed SA(WAR:GEN) is .
Does Genomed SA(WAR:GEN) pay dividends? If so, how much?
Genomed SA(WAR:GEN) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.